OncoC4 Inc is a clinical-stage biotechnology company focused on the development of innovative cancer immunotherapies. The company is dedicated to advancing its pipeline of novel therapeutic candidates designed to harness the power of the immune system to target and eliminate cancer cells, aiming to improve treatment outcomes for patients with various types of cancer.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.